BOTH GEFITINIB AND ERLOTINIB INDUCED DRUG-RELATED INTERSTITIAL LUNG DISEASE IN A PATIENT WITH PULMONARY ADENOCARCINOMA

147

  • CHANG, C-Y
  • WANG, K-F
  • CHANG, S-C
  • LIU, Y-C
Respirology 16:p 139-140, November 2011.
Copyright © 2011 Blackwell Publishing Ltd.